Procter & Gamble Hygiene and Health Care Limited PGHH.NS
IN · National Stock Exchange of India · XNSE · stock · Consumer Defensive · website
Procter & Gamble Hygiene and Health Care Limited financials (annual)
Bars are annual figures from 2022 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | ₹42.8B | ₹41.9B | ₹39.1B | ₹37.9B |
| Gross profit | ₹27.2B | ₹23.5B | ₹20.2B | ₹20.3B |
| SG&A expense | ₹5.2B | ₹6.6B | ₹5.5B | ₹6.1B |
| Operating income | ₹11.3B | ₹9.5B | ₹8.2B | ₹7.9B |
| Interest expense | ₹94.5M | ₹270.0M | ₹113.8M | ₹111.9M |
| Income tax | ₹3.1B | ₹2.6B | ₹1.6B | ₹2.1B |
| Net income | ₹8.6B | ₹6.8B | ₹6.8B | ₹5.8B |
| EPS (diluted) | — | ₹207.95 | ₹208.91 | ₹177.37 |
| Operating cash flow | ₹9.2B | ₹4.7B | ₹8.3B | ₹5.7B |
| Free cash flow | ₹8.7B | ₹4.3B | ₹7.8B | ₹5.2B |
| Cash & equivalents | ₹5.6B | ₹5.7B | ₹9.6B | ₹6.2B |
| Inventory | ₹2.2B | ₹2.3B | ₹2.2B | ₹2.3B |
| Total assets | ₹18.0B | ₹18.6B | ₹21.4B | ₹16.8B |
| Total debt | ₹8.7M | ₹30.8M | ₹40.3M | ₹51.0M |
| Total liabilities | ₹10.5B | ₹10.8B | ₹11.9B | ₹9.4B |
| Shareholders' equity | ₹7.5B | ₹7.7B | ₹9.5B | ₹7.4B |
Growth · year-over-year · Revenue CAGR 4.1%
| Metric | FY2026 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +2.1% | +7.3% | +3.0% | — |
| Net income growth | +26.9% | -0.5% | +17.8% | — |
| EPS growth | — | -0.5% | +17.8% | — |
| Free cash flow growth | +105.4% | -45.5% | +49.3% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · IN · as of 2026-03-31. Figures in INR. Facts plus Stocktoria's own computed scores — not investment advice.